<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Subjects with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> are at risk for vascular injury </plain></SENT>
<SENT sid="1" pm="."><plain>Several vasoactive factors (e.g., angiotensin) have been implicated </plain></SENT>
<SENT sid="2" pm="."><plain>We hypothesize that adrenomedullin, a novel vascoactive factor, is deranged in subjects with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>RESEARCH DESIGN AND METHODS: Using a new immunoluminometric method, plasma midregional proadrenomedullin (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>-proADM) was measured in four groups of Chinese subjects: healthy (n = 100, fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> [FPG] &lt;5.6 mmol/l), impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> (IFG) (n = 60, FPG 5.6-6.9 mmol/l), and diabetic subjects with (n = 100) and without (n = 100) <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Resting forearm cutaneous microcirculatory perfusion (RCMP) was quantified in vivo using 2-dimensional laser Doppler flowmetry </plain></SENT>
<SENT sid="5" pm="."><plain>We investigated the relationship between plasma <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>-proADM concentrations, multiple metabolic factors, and vascular function </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: We observed a stepwise increase in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>-proADM among the groups: healthy group mean +/- SD 0.27 +/- 0.09, IFG group 0.29 +/- 0.13, diabetic group 0.42 +/- 0.13, and diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> group 0.81 +/- 0.54 nmol/l (diabetic vs. healthy and IFG groups, P = 0.04; and diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> group vs. <z:hpo ids='HP_0000001'>all</z:hpo>, P &lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>Statistical adjustment for sex, age, BMI, and blood pressure did not affect the conclusions </plain></SENT>
<SENT sid="8" pm="."><plain>Multiple linear regression analysis revealed that highly sensitive C-reactive protein (beta = 0.11; P = 0.01), <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> index (beta = 0.20; P = 0.001), <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> (beta = 0.31; P &lt; 0.001), and adiponectin (beta = 0.33; P &lt; 0.001) were significant predictors of plasma <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>-proADM concentrations among nondiabetic individuals </plain></SENT>
<SENT sid="9" pm="."><plain>Among subjects with <z:mp ids='MP_0002055'>diabetes</z:mp>, plasma <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>-proADM concentrations correlated significantly with RCMP (r = 0.43, P = 0.002) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Plasma <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>-proADM concentration was elevated in subjects with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>This was further accentuated when <z:hpo ids='HP_0000112'>nephropathy</z:hpo> set in </plain></SENT>
<SENT sid="12" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>-proADM was related to multiple metabolic factors and basal microcirculatory perfusion </plain></SENT>
<SENT sid="13" pm="."><plain>Adrenomedullin might play a role in the pathogenesis of diabetic vasculopathy </plain></SENT>
</text></document>